Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
2479 | 3954 | 34.7 | 69% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
11 | 4 | NEUROSCIENCES//CLINICAL NEUROLOGY//NEUROL | 1112395 |
59 | 3 | ANESTHESIOLOGY//PAIN//CHRONIC PAIN | 88506 |
2479 | 2 | BREAKTHROUGH PAIN//CANCER PAIN//FENTANYL | 3954 |
5211 | 1 | BREAKTHROUGH PAIN//CANCER PAIN//FENTANYL | 1656 |
7391 | 1 | MORPHINE 6 GLUCURONIDE//OXYCODONE//MORPHINE 3 GLUCURONIDE | 1372 |
16064 | 1 | OPRM1//A118G//OPRM1 GENE | 675 |
30362 | 1 | COMPLICATIONS NORPETHIDINE TOXICITY//OPIOIDS PETHIDINE//PETHIDINE HYDROCHLORIDE | 170 |
36429 | 1 | KETOBEMIDONE//BUCCAL ABSORPTION PRODRUG//KAROLINSKA PHARM PEDIAT CANC UNIT | 81 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | BREAKTHROUGH PAIN | authKW | 1028651 | 4% | 85% | 157 |
2 | CANCER PAIN | authKW | 626394 | 8% | 25% | 322 |
3 | FENTANYL | authKW | 480353 | 8% | 20% | 311 |
4 | OXYCODONE | authKW | 474292 | 4% | 35% | 176 |
5 | MORPHINE 6 GLUCURONIDE | authKW | 410373 | 2% | 60% | 89 |
6 | OPIOID ROTATION | authKW | 338957 | 1% | 77% | 57 |
7 | MORPHINE 3 GLUCURONIDE | authKW | 289041 | 2% | 59% | 63 |
8 | OPRM1 | authKW | 253194 | 2% | 52% | 63 |
9 | PAIN RELIEF PALLIAT CARE UNIT | address | 252187 | 2% | 41% | 79 |
10 | TRANSDERMAL FENTANYL | authKW | 241909 | 1% | 61% | 51 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Anesthesiology | 34498 | 18% | 1% | 708 |
2 | Pharmacology & Pharmacy | 9303 | 30% | 0% | 1170 |
3 | Health Care Sciences & Services | 9244 | 11% | 0% | 423 |
4 | Clinical Neurology | 4321 | 16% | 0% | 616 |
5 | Medicine, General & Internal | 3110 | 14% | 0% | 564 |
6 | Neurosciences | 1028 | 12% | 0% | 466 |
7 | Medicine, Legal | 877 | 2% | 0% | 67 |
8 | Toxicology | 868 | 5% | 0% | 205 |
9 | Oncology | 656 | 9% | 0% | 346 |
10 | Emergency Medicine | 311 | 1% | 0% | 54 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | PAIN RELIEF PALLIAT CARE UNIT | 252187 | 2% | 41% | 79 |
2 | ANESTHESIA INTENS CARE UNIT | 64801 | 1% | 19% | 45 |
3 | PAIN MED PALLIAT CARE | 29203 | 1% | 15% | 25 |
4 | PALLIAT MED | 28959 | 2% | 5% | 73 |
5 | ANAESTHESIOL EMERGENCY MED | 28491 | 0% | 31% | 12 |
6 | MOL EPIDEMIOL PAIN PROGRAM | 27790 | 0% | 60% | 6 |
7 | PAIN RELIEF PALLIAT CARE | 27016 | 0% | 50% | 7 |
8 | HOME PALLIAT CARE PROGRAM | 25263 | 0% | 55% | 6 |
9 | ANESTHESIA INTENS CARE PAIN RELIEF PALLIAT | 24124 | 0% | 63% | 5 |
10 | LOTUS CLIN LLC | 23162 | 0% | 100% | 3 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF PAIN AND SYMPTOM MANAGEMENT | 88514 | 5% | 6% | 196 |
2 | PAIN | 22932 | 4% | 2% | 153 |
3 | PALLIATIVE MEDICINE | 18394 | 2% | 4% | 61 |
4 | ADVANCES IN PAIN RESEARCH AND THERAPY | 14970 | 1% | 6% | 35 |
5 | JOURNAL OF ANALYTICAL TOXICOLOGY | 13630 | 2% | 2% | 77 |
6 | EUROPEAN JOURNAL OF PAIN | 10877 | 1% | 3% | 54 |
7 | SUPPORTIVE CARE IN CANCER | 7758 | 2% | 2% | 66 |
8 | PAIN MEDICINE | 6579 | 1% | 2% | 41 |
9 | MEDICINA PALIATIVA | 6020 | 0% | 7% | 12 |
10 | CLINICAL DRUG INVESTIGATION | 5876 | 1% | 2% | 41 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | BREAKTHROUGH PAIN | 1028651 | 4% | 85% | 157 | Search BREAKTHROUGH+PAIN | Search BREAKTHROUGH+PAIN |
2 | CANCER PAIN | 626394 | 8% | 25% | 322 | Search CANCER+PAIN | Search CANCER+PAIN |
3 | FENTANYL | 480353 | 8% | 20% | 311 | Search FENTANYL | Search FENTANYL |
4 | OXYCODONE | 474292 | 4% | 35% | 176 | Search OXYCODONE | Search OXYCODONE |
5 | MORPHINE 6 GLUCURONIDE | 410373 | 2% | 60% | 89 | Search MORPHINE+6+GLUCURONIDE | Search MORPHINE+6+GLUCURONIDE |
6 | OPIOID ROTATION | 338957 | 1% | 77% | 57 | Search OPIOID+ROTATION | Search OPIOID+ROTATION |
7 | MORPHINE 3 GLUCURONIDE | 289041 | 2% | 59% | 63 | Search MORPHINE+3+GLUCURONIDE | Search MORPHINE+3+GLUCURONIDE |
8 | OPRM1 | 253194 | 2% | 52% | 63 | Search OPRM1 | Search OPRM1 |
9 | TRANSDERMAL FENTANYL | 241909 | 1% | 61% | 51 | Search TRANSDERMAL+FENTANYL | Search TRANSDERMAL+FENTANYL |
10 | BREAKTHROUGH CANCER PAIN | 196756 | 1% | 88% | 29 | Search BREAKTHROUGH+CANCER+PAIN | Search BREAKTHROUGH+CANCER+PAIN |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | ANDERSEN, G , CHRISTRUP, L , SJOGREN, P , (2003) RELATIONSHIPS AMONG MORPHINE METABOLISM, PAIN AND SIDE EFFECTS DURING LONG-TERM TREATMENT: AN UPDATE.JOURNAL OF PAIN AND SYMPTOM MANAGEMENT. VOL. 25. ISSUE 1. P. 74-91 | 100 | 88% | 52 |
2 | KING, S , FORBES, K , HANKS, GW , FERRO, CJ , CHAMBERS, EJ , (2011) A SYSTEMATIC REVIEW OF THE USE OF OPIOID MEDICATION FOR THOSE WITH MODERATE TO SEVERE CANCER PAIN AND RENAL IMPAIRMENT: A EUROPEAN PALLIATIVE CARE RESEARCH COLLABORATIVE OPIOID GUIDELINES PROJECT.PALLIATIVE MEDICINE. VOL. 25. ISSUE 5. P. 525 -552 | 95 | 67% | 45 |
3 | KILPATRICK, GJ , SMITH, TW , (2005) MORPHINE-6-GLUCURONIDE: ACTIONS AND MECHANISMS.MEDICINAL RESEARCH REVIEWS. VOL. 25. ISSUE 5. P. 521-544 | 110 | 68% | 74 |
4 | GRAPE, S , SCHUG, SA , LAUER, S , SCHUG, BS , (2010) FORMULATIONS OF FENTANYL FOR THE MANAGEMENT OF PAIN.DRUGS. VOL. 70. ISSUE 1. P. 57-72 | 73 | 88% | 43 |
5 | MERCADANTE, S , PORTENOY, RK , (2016) BREAKTHROUGH CANCER PAIN: TWENTY-FIVE YEARS OF STUDY.PAIN. VOL. 157. ISSUE 12. P. 2657 -2663 | 57 | 100% | 1 |
6 | DAVIS, MP , (2011) FENTANYL FOR BREAKTHROUGH PAIN: A SYSTEMATIC REVIEW.EXPERT REVIEW OF NEUROTHERAPEUTICS. VOL. 11. ISSUE 8. P. 1197 -1216 | 71 | 83% | 27 |
7 | SMITH, H , (2012) A COMPREHENSIVE REVIEW OF RAPID-ONSET OPIOIDS FOR BREAKTHROUGH PAIN.CNS DRUGS. VOL. 26. ISSUE 6. P. 509-535 | 59 | 91% | 23 |
8 | KLIMAS, R , MIKUS, G , (2014) MORPHINE-6-GLUCURONIDE IS RESPONSIBLE FOR THE ANALGESIC EFFECT AFTER MORPHINE ADMINISTRATION: A QUANTITATIVE REVIEW OF MORPHINE, MORPHINE-6-GLUCURONIDE, AND MORPHINE-3-GLUCURONIDE.BRITISH JOURNAL OF ANAESTHESIA. VOL. 113. ISSUE 6. P. 935 -944 | 58 | 85% | 12 |
9 | WIFFEN, PJ , WEE, B , MOORE, RA , (2016) ORAL MORPHINE FOR CANCER PAIN.COCHRANE DATABASE OF SYSTEMATIC REVIEWS. VOL. . ISSUE 4. P. - | 80 | 65% | 0 |
10 | LEPPERT, W , (2009) THE ROLE OF METHADONE IN CANCER PAIN TREATMENT - A REVIEW.INTERNATIONAL JOURNAL OF CLINICAL PRACTICE. VOL. 63. ISSUE 7. P. 1095 -1109 | 77 | 74% | 26 |
Classes with closest relation at Level 2 |